Sintilimab-induced erythema multiforme drug eruption in the treatment of sigmoid colon cancer: A case report and literature review

RATIONALE: Dermatologic toxicity has been reported as the most common immune-related side effect of programmed cell death 1 inhibitors. Previous reports related to Sintilimab include rash, pruritus, vitiligo, Stevens-Johnson syndrome, toxic epidermal necrolysis, and so on. PATIENT CONCERNS: A 66-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mei, Wu, Ran, Jia, Min, Sun, Shaoqin, Zhang, Lei, Tang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578730/
https://www.ncbi.nlm.nih.gov/pubmed/37832081
http://dx.doi.org/10.1097/MD.0000000000035659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578730/
https://www.ncbi.nlm.nih.gov/pubmed/37832081
http://dx.doi.org/10.1097/MD.0000000000035659

Ejemplares similares